# Acarbose

## Dibose 100mg

| 藥物代碼 | ODIBO |
| :--- | :--- |
| 適應症 | Diabetes mellitus, type 2: Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus \(noninsulin dependent, NIDDM\). |
| 副作用 | &gt;10%: Gastrointestinal: Frequency and intensity of flatulence \(74%\) tend to abate with time; diarrhea \(31%\) and abdominal pain \(19%\) tend to return to pretreatment levels over time.1% to 10%: Hepatic: Increased serum transaminases \(?4%\)&lt;1%, postmarketing, and/or case reports: Edema, erythema, hepatic injury, hepatitis, intestinal obstruction, jaundice, pneumatosis cystoides intestinalis, skin rash, thrombocytopenia, urticaria |
| 禁忌 | Hypersensitivity to acarbose or any component of the formulation; diabetic ketoacidosis; cirrhosis; inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, patients predisposed to intestinal obstruction; chronic intestinal diseases associated with marked disorders of digestion or absorption; conditions that may deteriorate as a result of increased gas formation in the intestine. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult: Initially 50 mg tid, up to 100 mg tid. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

